S.D. Admin. R. 20:48:04:10

Current through Register Vol. 50, page 159, June 17, 2024

Section 20:48:04:10 - Scope and standards of nurse anesthetist practice - Controlled substance prescribing

Prior to prescribing any controlled substances listed in SDCL chapter 34-20 B, a nurse anesthetist that meets state and federal controlled substance registration requirements, shall register with the state's prescription drug monitoring program (PDMP) and meet requirements in SDCL chapter 34-20 E-

The standards for documentation of patient care when prescribing controlled substance drugs for the treatment of chronic, non-cancer pain include:

(1) Documentation of results of medical examinations, diagnostic or laboratory tests:

(2) Documentation of a patient's medical and psychosocial history;

(3) Documentation of advanced comprehensive nursing assessment:

(4) Documentation that appropriate state PDMPs were accessed:

(5) Documentation of a patient's treatment agreement, if used:

(6) Documentation of having provided instructions to the patient, or patient's representative, of the benefits and risks of controlled substances, proper use and storage of drugs, and proper disposal of unused drugs:

(7) When prescribing opioid drugs, documentation of instructions including the risk of addiction, overdose, and death, and use of naloxone products to reverse overdose as defined in SDCL chapter 34-20 A:

(8) Documentation of progress or lack of progress of pain management and functional improvement: and

(9) Documentation of collaboration with other health care providers.

Chronic pain is defined as a client who is experiencing ongoing, recurrent or persistent pain lasting beyond the usual course of an acute illness or injury or that is three months or longer in duration.

S.D. Admin. R. 20:48:04:10

47 SDR 073, effective 12/21/2020

General Authority: SDCL 36-9-3.1.

Law Implemented: SDCL 1-26, 34-20A. 34-2QB, 34-20E, 36-9-49(5), (7). and (10).